Multiplexed Plasma Immune Mediator Signatures Can Differentiate Sepsis From NonInfective SIRS: American Surgical Association 2020 Annual Meeting Paper. Issue 4 (October 2020)

• Record Type: Journal Article
• Authors: Cahill, Laura A.; Joughin, Brian A.; Kwon, Woon Yong; Itagaki, Kiyoshi; Kirk, Charlotte H.; Shapiro, Nathan I.; Otterbein, Leo E.; Yaffe, Michael B.; Lederer, James A.; Hauser, Carl J.
• Is Part Of: Annals of surgery. Volume 272:Issue 4(2020)
• Publication Date: 2020-10
• Subjects: bioinformatics -- biomarkers -- inflammation -- sepsis -- SIRS -- sterile injury; Surgery -- Periodicals; 617.005
• DOI: 10.1097/SLA.0000000000004379
• Languages: English
• ISSNs: 0003-4932

Abstract

Abstract : Objectives: Sepsis and sterile both release "danger signals" that induce the systemic inflammatory response syndrome (SIRS). So differentiating infection from SIRS can be challenging. Precision diagnostic assays could limit unnecessary antibiotic use, improving outcomes. Methods: After surveying human leukocyte cytokine production responses to sterile damage-associated molecular patterns (DAMPs), bacterial pathogen-associated molecular patterns, and bacteria we created a multiplex assay for 31 cytokines. We then studied plasma from patients with bacteremia, septic shock, "severe sepsis, " or trauma (ISS ≥15 with circulating DAMPs) as well as controls. Infections were adjudicated based on post-hospitalization review. Plasma was studied in infection and injury using univariate and multivariate means to determine how such multiplex assays could best distinguish infective from noninfective SIRS. Results: Infected patients had high plasma interleukin (IL)-6, IL-1α, and triggering receptor expressed on myeloid cells-1 (TREM-1) compared to controls [false discovery rates (FDR) <0.01, <0.01, <0.0001]. Conversely, injury suppressed many mediators including MDC (FDR <0.0001), TREM-1 (FDR <0.001), IP-10 (FDR <0.01), MCP-3 (FDR <0.05), FLT3L (FDR <0.05), Tweak, (FDR <0.05), GRO-α (FDR <0.05), and ENA-78 (FDR <0.05). In univariate studies, analyte overlap between clinical groups prevented clinical relevance. Multivariate models discriminated injury and infection much better, with the 2-group random-forest model classifying 11/11 injury and 28/29 infection patients correctly in out-of-bag validation. Conclusions: Circulating cytokines in traumatic SIRS differ markedly from those in health or sepsis. Variability limits the accuracy of single-mediator assays but machine learning based on multiplexed plasma assays revealed distinct patterns in sepsis- and injury-related SIRS. Defining biomarker release patterns that distinguish specific SIRS populations might allow decreased antibiotic use in those clinical situations. Large prospective studies are needed to validate and operationalize this approach. Abstract : Supplemental Digital Content is available in the text